In September, Hyderabad-based Aurobindo announced that it would acquire the commercial operations of Swiss drug maker Novartis AGsâ generics unit in the US for $900 million. However, the proposed deal, which could emerge as the largest outbound deal by an Indian company, is yet to see the light of day considering that the FTC is yet to respond.
from Moneycontrol Business News https://www.moneycontrol.com/news/business/aurobindoâs-sandoz-deal-may-face-further-delays_12818221.html
A great way to Earn Money Online in India without Investment.This blog is very useful to students and home makers to generate more side income.Here you will find more than 500 ways to Earn Money Online In India..
Subscribe to:
Post Comments (Atom)
Who is Ebrahim Raisi, Iran's president whose helicopter suffered a 'hard landing' in foggy weather?
News of his helicopter making what state media described as a "hard landing" on Sunday immediately brought new attention to the le...
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
The EUA will facilitate broader use of remdesivir to treat hospitalized patients with severe COVID-19 disease, enabling access to remdesivi...
No comments:
Post a Comment